NEW YORK (GenomeWeb News) – NanoString Technologies reported after the close of the market Tuesday that its third quarter revenues climbed 39 percent as the firm reported growth for both its instruments and consumables.

The Seattle-based company brought in total revenues of $8.4 million for the three months ended Sept. 30, compared to $6 million for the third quarter of 2012. NanoString beat analysts' consensus estimate for revenues of $7.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.